Cicloprololum[Latin] 1-[4-[2-(环丙基甲氧基)乙氧基]苯氧基]-3-[(异丙基)氨基]-2-丙醇盐酸盐
CAS 63686-79-3 MFCD N/A
化学结构图
SMILES:
化学属性
| Mol. Formula | C18H29NO4.ClH |
|---|---|
| Mol. Weight | 359.94 |
别名和识别编码
| Chemical Name | 2-Propanol,1-(4-(2-(cyclopropylmethoxy)ethoxy)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride |
|---|---|
| Chemical Name Translation | 1-[4-[2-(环丙基甲氧基)乙氧基]苯氧基]-3-[(异丙基)氨基]-2-丙醇盐酸盐 |
| Chemicalbook ID | CB11246781 |
| Wiswesser Line Notation | L3TJ A1O2OR DO1YQ1MY1&1 &GH |
| Synonym | 1-(4-(2-(Cyclopropylmethoxy)ethoxy)phenoxy)-3-isopropylaminopropan-2-ol |
| CAS Number | 63686-79-3 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Cocco G, et al. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure. Clin Cardiol. 1992 Jan;15(1):38-42.
- [1]. Weber S, et al. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects. Br J Clin Pharmacol. 1990 Sep;30(3):411-6
- [1]. Weber S, et al. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects. Br J Clin Pharmacol. 1990 Sep;30(3):411-6
- [2]. Cocco G, et al. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure. Clin Cardiol. 1992 Jan;15(1):38-42.
安全信息
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 610 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4252984
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 76 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4252984
